BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/3/2015 5:30:00 PM | Browse: 1348 | Download: 1804
|
Received |
|
2015-04-17 08:48 |
|
Peer-Review Started |
|
2015-04-18 17:20 |
|
To Make the First Decision |
|
2015-05-18 13:04 |
|
Return for Revision |
|
2015-05-20 12:11 |
|
Revised |
|
2015-06-19 10:56 |
|
Second Decision |
|
2015-09-12 21:57 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2015-09-14 11:10 |
|
Articles in Press |
|
2015-09-14 11:11 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2015-09-24 07:44 |
|
Typeset the Manuscript |
|
2015-10-20 13:08 |
|
Publish the Manuscript Online |
|
2015-11-03 17:31 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis
|
Manuscript Source |
Invited Manuscript |
All Author List |
Ming Luo, Jian-Yang Guo and Wu-Kui Cao |
Funding Agency and Grant Number |
|
Corresponding Author |
Wu-Kui Cao, PhD, Tianjin Liver Disease Institute, Tianjin Second People’s Hospital, No. 75 Sudi Road, Nankai District, Tianjin 300192, China. caowukui@126.com |
Key Words |
Inflammation; Hepatic encephalopathy; Pathogenesis; Treatment |
Core Tip |
Currently, inflammation appears to play a critical role in the pathogenesis of hepatic encephalopathy (HE) and is gradually being considered a critical therapeutic target for HE in patients with liver cirrhosis. Current therapies for HE, including lactulose, rifaximin, probiotics and the molecular adsorbent recirculating system, have been found to improve clinical manifestations and prevent the progression of HE by ameliorating inflammation in cirrhotic patients. This review will provide an overview of the inflammatory pathogenesis of HE, focusing on the recent findings on its therapeutic manipulation. |
Publish Date |
2015-11-03 17:31 |
Citation |
Luo M, Guo JY, Cao WK. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis. World J Gastroenterol 2015; 21(41): 11815-11824 |
URL |
http://www.wjgnet.com/1007-9327/full/v21/i41/11815.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v21.i41.11815 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345